Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cell cycle progression without cyclin D-CDK4 and cyclin D-CDK6 complexes.

Katarzyna Kozar1, Piotr Sicinski

  • 1Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.

Cell Cycle (Georgetown, Tex.)
|March 2, 2005
PubMed
Summary

D-type cyclins and cyclin-dependent kinases CDK4/6 are not essential for all cell proliferation. Some cells can grow and divide independently of this cyclin D-CDK4/6 pathway.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Avutometinib, Abemaciclib, and Fulvestrant in Patients with HR+/HER2- Metastatic Breast Cancer Previously Treated with CDK4/6 Inhibitor: A Single-Arm Phase I Trial.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

ESR1 mutations and CDK4/6 inhibitor choice shape clonal selection and adaptive cell states during acquired resistance.

Genome medicine·2026
Same author

HER2 heterogeneous breast cancer models reveal novel therapeutic targets and subclonal dynamics during evolution to resistance to HER2-targeted therapies.

Cancer discovery·2026
Same author

Regulation of the immune CD155-CD226-TIGIT axis by cyclin D-CDK4/6.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Transcriptional cyclin-dependent kinases Cdk8 and Cdk19 are required for normal macrophage differentiation.

Cell cycle (Georgetown, Tex.)·2025
Same author

Targeting Transcriptional Cyclin-Dependent Kinases in Cancer.

Molecular cancer therapeutics·2025

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Genetics

Background:

  • D-type cyclins (cyclin D1, D2, D3) and their partners CDK4/6 are considered key regulators of the cell cycle.
  • Their precise role in cell proliferation across different tissues has been a subject of ongoing research.

Purpose of the Study:

  • To investigate the essentiality of the cyclin D-CDK4/6 complex in cell proliferation.
  • To determine if cell division can occur independently of cyclin D-CDK4/6 activity.

Main Methods:

  • Analysis of genetically modified mice lacking D-cyclins or CDK4/6.
  • Observation and characterization of cell proliferation in various compartments of these knockout mice.

Main Results:

  • Mice lacking D-cyclins or CDK4/6 exhibited impaired proliferation in specific cell types.

Related Experiment Videos

  • Crucially, several cellular compartments were observed to develop and proliferate normally, even without cyclin D-CDK4/6 activity.
  • This indicates a cyclin D-independent proliferation mechanism exists.

    • Conclusions:

    • The cyclin D-CDK4/6 pathway is not universally essential for cell proliferation.
    • Certain cell types possess alternative mechanisms to drive cell division, independent of cyclin D-CDK4/6.
    • These findings redefine the understanding of cell cycle regulation and highlight cellular plasticity.